502
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Incidence of virulence determinants among Streptococcus agalactiae isolated from pregnant women and association with their serotypes

, , , &
Pages 650-670 | Received 04 Jun 2023, Accepted 12 Jul 2023, Published online: 19 Sep 2023

References

  • Delfani S, Bahmani M, Mohammadrezaei-Khorramabadi R, et al. Phytotherapy in streptococcusagalactiae: an overview of the medicinal plants effective against streptococcus agalactiae. J Clin Diagn Res. 2017;11(6):De01–de02. doi: 10.7860/JCDR/2017/25530.9988
  • Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev. 1998;11(3):497–513. doi: 10.1128/CMR.11.3.497
  • Barcaite EB, Tameliene A, Kliucinskas R, et al. Prevalence of maternal group B streptococcal colonisation in European countries. Acta Obstet Gynecol Scand. 2008;87(3):260–271. doi: 10.1080/00016340801908759
  • Ippolito DL, James WA, Tinnemore D, et al. Group B streptococcus serotype prevalence in reproductive-age women at a tertiary care military medical center relative to global serotype distribution. BMC Infect Dis. 2010;10(1):336. doi: 10.1186/1471-2334-10-336
  • Raabe VN, Shane AL. Group B Streptococcus (Streptococcus agalactiae). Microbiol Spectr. 2019;7(2):10.1128/microbiolspec.GPP3-0007-2018. doi: 10.1128/microbiolspec.GPP3-0007-2018
  • Khademi F, Sahebkar A. Group B streptococcus drug resistance in pregnant women in Iran: a meta-analysis. Taiwanese J Obstetrics Gynecol. 2020;59(5):635–642. doi: 10.1016/j.tjog.2020.07.002
  • Santana FAF, de Oliveira TVL, de Souza Filho MB, et al. Streptococcus agalactiae: identification methods, antimicrobial susceptibility, and resistance genes in pregnant women. World J Clin Cases. 2020;8(18):3988–3998. doi: 10.12998/wjcc.v8.i18.3988
  • Bobadilla FJ, Novosak MG, Cortese IJ, et al. Prevalence, serotypes and virulence genes of streptococcus agalactiae isolated from pregnant women with 35–37 weeks of gestation. BMC Infect Dis. 2021;21(1):73. doi: 10.1186/s12879-020-05603-5
  • Jarva H, Hellwage J, Jokiranta TS, et al. The group b streptococcal β and pneumococcal hic proteins are structurally related immune evasion molecules that bind the complement inhibitor factor h in an analogous fashion 1. J Immunol. 2004;172(5):3111–3118. doi: 10.4049/jimmunol.172.5.3111
  • Jerlström PG, Chhatwal GS, Timmis KN. The IgA-binding beta antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions. Mol Microbiol. 1991;5(4):843–849. doi: 10.1111/j.1365-2958.1991.tb00757.x
  • Slotved HC, Kong F, Lambertsen L, et al. Serotype IX, a proposed new streptococcus agalactiae serotype. J Clin Microbiol. 2007;45(9):2929–2936. doi: 10.1128/JCM.00117-07
  • Johri AK, Paoletti LC, Glaser P, et al. Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol. 2006;4(12):932–942. doi: 10.1038/nrmicro1552
  • Matsubara K, Mikamo H, Numa M, et al. Three fatal cases of invasive serotype VI group B streptococcal infection. J Infect. 2006;53(3):139–142. doi: 10.1016/j.jinf.2005.11.023
  • Hall J, Adams NH, Bartlett L, et al. Maternal disease with group B Streptococcus and serotype distribution worldwide: systematic review and meta-analyses. Clinl Infect Dis. 2017;65(suppl_2):S112–S124. doi: 10.1093/cid/cix660
  • Russell NJ, Seale AC, O’Driscoll M, et al. Maternal colonization with group B Streptococcus and serotype distribution worldwide: systematic review and meta-analyses. Clinl Infect Dis. 2017;65(suppl_2):S100–S111. doi: 10.1093/cid/cix658
  • Sadeh M, Firouzi R, Derakhshandeh A, et al. Molecular characterization of streptococcus agalactiae isolates from pregnant and non-pregnant women at yazd university hospital, Iran. Jundishapur J Microbiol. 2016;9(2):e30412. doi: 10.5812/jjm.30412
  • Vornhagen J, Adams Waldorf KM, Rajagopal L. Perinatal group b streptococcal infections: virulence factors, immunity, and prevention strategies. Trends Microbiol. 2017;25(11):919–931. doi: 10.1016/j.tim.2017.05.013
  • Konto-Ghiorghi YM, Mallet E, Duméni A, et al. Dual role for pilus in adherence to epithelial cells and biofilm formation in Streptococcus agalactiae. PLoS Pathog. 2009;5(5):e1000422. doi: 10.1371/journal.ppat.1000422
  • Xia FD, Mallet A, Caliot E, et al. Capsular polysaccharide of Group B Streptococcus mediates biofilm formation in the presence of human plasma. Microbes Infect. 2015;17(1):71–76. doi: 10.1016/j.micinf.2014.10.007
  • Vornhagen J, Quach PB, Merillat E, et al. Bacterial hyaluronidase promotes ascending GBS infection and preterm birth. MBio. 2016;7(3). doi: 10.1128/mBio.00781-16
  • Liu Y, Liu J. Group B streptococcus: virulence factors and pathogenic mechanism. Microorganisms. 2022;10(12). doi: 10.3390/microorganisms10122483
  • Whidbey C, Harrell MI, Burnside K, et al. A hemolytic pigment of group b streptococcus allows bacterial penetration of human placenta. J Exp Med. 2013;210(6):1265–1281. doi: 10.1084/jem.20122753
  • Tazi A, Disson O, Bellais S, et al. The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates. J Exp Med. 2010;207(11):2313–2322. doi: 10.1084/jem.20092594
  • Hensler ME, Quach D, Hsieh C-J, et al. CAMP factor is not essential for systemic virulence of group b streptococcus. Microb Pathog. 2008;44(1):84–88. doi: 10.1016/j.micpath.2007.08.005
  • Hannoun A, Shehab M, Khairallah M-T, et al. Correlation between group b streptococcal genotypes, their antimicrobial resistance profiles, and virulence genes among pregnant women in lebanon. Int J Microbiol. 2009;2009:1–6. DOI:10.1155/2009/796512
  • Bauer AW, Kirby WMM, Sherris JC, et al. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45(4):493–496. doi: 10.1093/ajcp/45.4_ts.493
  • CLSI. Clinical and Laboratory Standards Institute Methods for dilution of antimicrobial susceptibility for bacteria that grow aerobically. Approved Standard 10th ed. Wayne (PA): Clinical and Laboratory Standards Institute M100; 2019. (CLSI Document M07-A10).
  • Lancefield RC, McCarty M, Everly WNJTJOEM. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J Exp Med. 1975;142(1):165–179. doi: 10.1084/jem.142.1.165
  • Stepanović S, Vuković D, Dakić I, et al. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 2000;40(2):175–179. doi: 10.1016/S0167-7012(00)00122-6
  • Sato T, Kamaguchi A, Nakazawa F. Purification and characterization of hemolysin from Prevotella oris. J Oral Biosci. 2012;54(2):113–118. doi: 10.1016/j.job.2012.03.002
  • Sambrook J, Russell D. Molecular Cloning: A Laboratory Manual (3-Volume Set). Vol. 1. New York: Spring Harbor Laboratory Press; 2001.
  • Teatero S, McGeer A, Low DE, et al. Characterization of invasive group b streptococcus strains from the greater toronto area canada. J Clin Microbiol. 2014;52(5):1441–1447. doi: 10.1128/JCM.03554-13
  • Sadeh M, Firouzi R, Derakhshandeh A, et al. Molecular characterization of streptococcus agalactiae isolates from pregnant and non-pregnant women at yazd university hospital, iran jundishapur. J Microbiol. 2016;9(2):e30412–e30412. doi: 10.5812/jjm.30412
  • Rojo-Bezares B, AZCONA-GUTIérrez JM, MARTIN C, et al. Streptococcus agalactiae from pregnant women: antibiotic and heavy-metal resistance mechanisms and molecular typing. Epidemiol Infect. 2016;144(15):3205–3214. doi: 10.1017/S0950268816001692
  • Shabayek S. Prevalence of group B streptococcus among pregnant and non-pregnant women in Ismailia. Egypt Records of Pharmaceutical and Biomedical Sciences. 2017;1(1):6–16.
  • Elbaradie SM, Mahmoud M, Farid M. Maternal and neonatal screening for Group B streptococci by SCP B gene based PCR: a preliminary study. Indian J Med Microbiol. 2009;27(1):17–21. doi: 10.1016/S0255-0857(21)01746-1
  • Mohammed MA, Daniel, W, Yimtubezinash, D. Prevalence of group B Streptococcus colonization among pregnant women attending antenatal clinic of Hawassa Health Center, Hawassa, Ethiopia. Ethiopian Journal of Health Development. 2012;26(1):36–42.
  • Bassir A, Dhibou H, Farah M, et al. Portage vaginal du streptocoque du groupe B chez la femme enceinte au niveau de la région de Marrakech. Pan Afr Med J. 2016;23:23. DOI:10.11604/pamj.2016.23.107.9047
  • Nkembe NMK, Baiye HG, Chafa WA, et al. Streptococcus agalactiae prevalence and antimicrobial susceptibility pattern in vaginal and anorectal swabs of pregnant women at a tertiary hospital in Cameroon. BMC Res Notes. 2018;11(1):480. doi: 10.1186/s13104-018-3589-x
  • Dzowela T, Komolafe O, Igbigbi AJMMJ. Prevalence of group b streptococcus colonization in antenatal women at the queen elizabeth central hospital, blantyre–a preliminary study. Malawi Med J. 2005;17(3):97–99. doi: 10.4314/mmj.v17i3.10888
  • Schuchat A, Wenger JD. Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. Epidemiol Rev. 1994;16(2):374–402. doi: 10.1093/oxfordjournals.epirev.a036159
  • Akpaka PEH, Khamiya, T, Reinand, U, et al. Colonization of streptococcus agalactiae among pregnant patients in trinidad and Tobago. IJID Regions. 2022;3:96–100. doi: 10.1016/j.ijregi.2022.03.010
  • Valkenburg-van den Berg AW, Sprij AJ, Oostvogel PM, et al. Prevalence of colonisation with group b streptococci in pregnant women of a multi-ethnic population in the Netherlands. Eur J Obstet Gynecol Reprod Biol. 2006;124(2):178–183. doi: 10.1016/j.ejogrb.2005.06.007
  • Mubashir K, Faiz A, Ashshi A. Maternal colonization of group B streptococcus: Prevalence, associated factors and antimicrobial resistance. Ann Saudi Med. 2015;35(6):423–427. doi: 10.5144/0256-4947.2015.423
  • Joachim A, Matee MI, Massawe FA, et al. Maternal and neonatal colonisation of group B streptococcus at muhimbili national hospital in dar es Salaam, Tanzania: prevalence, risk factors and antimicrobial resistance. BMC Public Health. 2009;9(1):437. doi: 10.1186/1471-2458-9-437
  • Wang P, Tong J-J, Ma X-H, et al. Serotypes, antibiotic susceptibilities, and multi-locus sequence type profiles of Streptococcus agalactiae isolates circulating in Beijing, China. Plos One. 2015;10(3):e0120035. doi: 10.1371/journal.pone.0120035
  • Yao K, Poulsen K, Maione D, et al. Capsular gene typing of Streptococcus agalactiae compared to serotyping by latex agglutination. J Clin Microbiol. 2013;51(2):503–507. doi: 10.1128/JCM.02417-12
  • Suhaimi MES, Desa MNM, Eskandarian N, et al. Characterization of a group b streptococcus infection based on the demographics, serotypes, antimicrobial susceptibility and genotypes of selected isolates from sterile and non-sterile isolation sites in three major hospitals in Malaysia. J Infect Public Health. 2017;10(1):14–21. doi: 10.1016/j.jiph.2016.01.009
  • Toniolo C, Balducci E, Romano MR, et al. Streptococcus agalactiae capsule polymer length and attachment is determined by the proteins CpsABCD. J Biol Chem. 2015;290(15):9521–9532. doi: 10.1074/jbc.M114.631499
  • Li L, Wang R, Huang Y, et al. High incidence of pathogenic streptococcus agalactiae st485 strain in pregnant/puerperal women and isolation of hyper-virulent human cc67 strain. Front Microbiol. 2018;9:9. DOI:10.3389/fmicb.2018.00050
  • Melo SC, SANTOS NCDS, OLIVEIRA MD, et al. ANTIMICROBIAL SUSCEPTIBILITY of Streptococcus agalactiae ISOLATED from PREGNANT WOMEN. Rev Inst Med Trop Sao Paulo. 2016;58 83. doi: 10.1590/S1678-9946201658083
  • Mengist A, Kannan H, Abdissa A. Prevalence and antimicrobial susceptibility pattern of anorectal and vaginal group B streptococci isolates among pregnant women in Jimma, Ethiopia. BMC Res Notes. 2016;9(1):351. doi: 10.1186/s13104-016-2158-4
  • Michael Ruess UMASRB. Antimicrobial susceptibility patterns of streptococcus agalactiae in a German University Hospital. Scand J Infect Dis. 2000;32(6):623–626. doi: 10.1080/003655400459522
  • Jain B, Tewari A, Bhandari BB, et al. Antibiotic resistance and virulence genes in streptococcus agalactiae isolated from cases of bovine subclinical mastitis. Veterinary Archievs. 2012;82:423–432.
  • Geng Y, Wang KY, Huang XL, et al. Streptococcus agalactiae, an emerging pathogen for cultured ya-fish, Schizothorax prenanti, in China. transbound emerg dis. Transbound Emerg Dis. 2012;59(4):369–375. doi: 10.1111/j.1865-1682.2011.01280.x
  • Mohamed Sadaka S, Abdelsalam Aly H, Ahmed Meheissen M, et al. Group B streptococcal carriage, antimicrobial susceptibility, and virulence related genes among pregnant women in Alexandria, Egypt. Alexandria J Med. 2018;54(1):69–76. doi: 10.1016/j.ajme.2017.01.003
  • Khan MA, Faiz A, Ashshi AMJAOSM. Maternal colonization of group B streptococcus: prevalence, associated factors and antimicrobial resistance. Ann Saudi Med. 2015;35(6):423–427. doi: 10.5144/0256-4947.2015.423
  • Motlová J, Straková L, Urbásková P, et al. Vaginal & rectal carriage of streptococcus agalactiae in the czech republic: incidence, serotypes distribution & susceptibility to antibiotics. Indian J Med Res. 2004;119:84–87.
  • Lambiase A, Agangi A, Del Pezzo M, et al. In vitro resistance to macrolides and clindamycin by group b streptococcus isolated from pregnant and nonpregnant women. Infect Dis Obstet Gynecol. 2012;2012:1–5. DOI:10.1155/2012/913603
  • Emaneini M. High incidence of macrolide and tetracycline resistance among Streptococcus agalactiae strains isolated from clinical samples in Tehran, Iran. Maedica. 2014;9(2):157.
  • Genovese C, D’Angeli F, Di Salvatore V, et al. Streptococcus agalactiae in pregnant women: serotype and antimicrobial susceptibility patterns over five years in Eastern Sicily (Italy). Eur J Clin Microbiol Infect Dis. 2020;39(12):2387–2396. doi: 10.1007/s10096-020-03992-8
  • Khan F, Shukla I, Rizvi M, et al. Detection of biofilm formation in staphylococcus aureus. does it have a role in treatment of mrsa infections. Trends In Medical Research. 2011;6(2):116–123. doi: 10.3923/tmr.2011.116.123
  • Cho KH, Caparon MG. Patterns of virulence gene expression differ between biofilm and tissue communities of Streptococcus pyogenes. Mol Microbiol. 2005;57(6):1545–1556. doi: 10.1111/j.1365-2958.2005.04786.x
  • Kaczorek-Łukowska E, Małaczewska J, Wójcik R, et al. Biofilm production and other virulence factors in Streptococcus spp. isolated from clinical cases of bovine mastitis in Poland. Access Microbiology. 2019;1(1A):1. doi: 10.1099/acmi.ac2019.po0442
  • Martins ER, Andreu A, Correia P, et al. Group B streptococci causing neonatal infections in barcelona are a stable clonal population: 18-year surveillance. J Clin Microbiol. 2011;49(8):2911–2918. doi: 10.1128/JCM.00271-11
  • Sharma D, Misba L, Khan AU, et al. Antibiotics versus biofilm: an emerging battleground in microbial communities. Antimicrob Resist Infect Control. 2019;8(1):1–10. doi: 10.1186/s13756-019-0533-3
  • Vestby LK, Grønseth T, Simm R, et al. Bacterial biofilm and its role in the pathogenesis of disease. Antibiotics. 2020;9(2):59. doi: 10.3390/antibiotics9020059
  • Amin M, Navidifar T, Saleh Shooshtari F, et al. Association between biofilm formation, structure, and the expression levels of genes related to biofilm formation and biofilm-specific resistance of acinetobacter baumannii strains isolated from burn infection in Ahvaz, Iran. Infection And Drug Resistance 2019: p. 3867–3881. Volume 12 10.2147/IDR.S228981.
  • Rosa-Fraile M, Dramsi S, Spellerberg B. Group B streptococcal haemolysin and pigment, a tale of twins. FEMS Microbiol Rev. 2014;38(5):932–946. doi: 10.1111/1574-6976.12071
  • Oviedo P, Pegels E, Laczeski M, et al. Phenotypic and genotypic characterization of streptococcus agalactiae in pregnant women. first study in a province of Argentina. Braz J Microbiol. 2013;44(1):253–258. doi: 10.1590/S1517-83822013005000030
  • Dutra VG, Alves VM, Olendzki AN, et al. Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility. BMC Infect Dis. 2014;14(1):323. doi: 10.1186/1471-2334-14-323
  • Udo EE, Boswihi SS, Al-Sweih N. Genotypes and virulence genes in group b streptococcus isolated in the Maternity Hospital, Kuwait. Med Princ Pract. 2013;22(5):453–457. doi: 10.1159/000349932
  • Souza VC, Kegele FCO, Souza SR, et al. Antimicrobial susceptibility and genetic diversity of Streptococcus agalactiae recovered from newborns and pregnant women in Brazil. Scand J Infect Dis. 2013;45(10):780–785. doi: 10.3109/00365548.2013.810814
  • Shabayek S, Spellerberg B. Group bstreptococcal colonization, molecular characteristics, and epidemiology. Front Microbiol. 2018;9:9. doi: 10.3389/fmicb.2018.00437
  • Dore N, BENNETT D, KALISZER M, et al. Molecular epidemiology of group B streptococci in Ireland: associations between serotype, invasive status and presence of genes encoding putative virulence factors. Epidemiol Infect. 2003;131(2):823–833. doi: 10.1017/S0950268803008847
  • Manning SD, Ki M, Marrs CF, et al. The frequency of genes encoding three putative group B streptococcal virulence factors among invasive and colonizing isolates. BMC Infect Dis. 2006;6(1):116. doi: 10.1186/1471-2334-6-116